Abstract
Five non-infectious problems of travel are set out in this chapter. Not all of them need to be discussed with every traveller, but travel medicine practitioners need to be well acquainted with each. Section 6.1, Fitness to Fly, summarises some hazards of and contraindications to air travel. This section is relevant for travellers with special needs. Section 6.2, Motion Sickness, provides the necessary information to advise travellers who seek help with this sometimes distressing problem. Jet lag (Sect. 6.3) is a problem for many who cross several time zones and is worth discussing with those involved in important activities where alertness and a high level of functioning are crucial within the first few days after arrival. Venous thromboembolism (Sect. 6.4) should be discussed with all travellers who may be at increased risk. Altitude illness (Sect. 6.5) should be discussed with all travellers going to altitudes higher than 2500 m, and the table of altitudes of various destinations in this chapter can be useful.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mieske K, Flaherty G, O’Brien T. Journeys to high altitude—risks and recommendations for travellers. J Travel Med. 2010;17(1):48–62.
Luks AM, McIntosh SE, et al. Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update. Wilderness Environ Med. 2014;25:S4–S14.
Key Reading
Fitness to Fly
Hu X, Cowl CT, Baqir M, Ryu JH. Air travel and pneumothorax. Chest. 2014;145:688–94.
Humphreys S, Deyermond R, Bali I, Stevenson M, Fee JP. The effect of high altitude commercial air travel on oxygen saturation. Anaesthesia. 2005;60(5):458–60.
Muhm JM, Rock PB, McMullin DL, et al. Effect of aircraft-cabin altitude on passenger discomfort. N Engl J Med. 2007;357:18–27.
Nable JV, Tupe CL, Gehle BD, Brady WJ. In-flight medical emergencies during commercial travel. N Engl J Med. 2015;373:939–45.
Sheffield PJ. Flying after diving guidelines: a review. Aviat Space Environ Med. 1990;61:1130–8.
Motion Sickness
Brainard A, Gresham C. Prevention and treatment of motion sickness. Am Fam Physician. 2014;90(1):41–6.
eTG Complete [Internet]. Melbourne (VIC). Therapeutic guidelines limited, 2017. Neurology expert group: motion sickness. (eTG July 2018 edition). 2018. https://tgldcdp.tg.org.au/etgcomplete. Accessed 12/12/2018.
Golding JF, Gresty MA. Pathophysiology and treatment of motion sickness. Curr Opin Neurol. 2015;28(1):83–8.
Graudins LV. Preventing motion sickness in children. Aust Prescr. 2009;32:61–3. https://www.nps.org.au/australian-prescriber/articles/preventing-motion-sickness-in-children. Accessed 12/12/2018.
Murdin L, Golding J, Bronstein A. Managing motion sickness. BMJ. 2011;343:d7430.
Wilson N. Sea sickness: cruising towards a healthy holiday. Aust J Pharm. 2017;98(1161):81–3.
Jet Lag
Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336(3):186–95.
Brown GM, et al. Melatonin and its relevance to jet lag. Travel Med Infect Dis. 2009;7:69–81.
Herxheimer A. Jet lag. BMJ Clin Evid. 2014;4:2303.
Sack RL. Clinical practice. Jet lag. N Engl J Med. 2010;362(5):440–7.
Suhner A, Schlagenhauf P, Tschopp A, Hauri-Bionda R, et al. Impact of melatonin on driving performance. J Travel Med. 1998;5:7–13.
Venous Thromboembolism
Cesarone MR, Belcaro G, Nicolaides AN, Incandela L, et al. Venous thrombosis from air travel: the LONFLIT3 study. Prevention with aspirin vs low-molecular weight heparin (LMWH) in high-risk subjects: a randomised trial. Angiology. 2002;53(1):1–6.
Kelman CW, Kortt MA, Becker NG, Li Z, et al. Deep vein thrombosis and air travel: record linkage study. BMJ. 2003;327(7423):1072.
Lapostolle F, Surget V, Borron SW, Desmaizieres M, et al. Severe pulmonary embolism associated with air travel. N Engl J Med. 2001;345(11):779–83.
Philbrick JT, Shumate R, Siadatay MS, Becker DM. Air travel and venous thromboembolism: a systematic review. J Gen Intern Med. 2007;22:107–14.
Ringwald J, et al. The place of new oral anticoagulants in travel medicine. Travel Med Infect Dis. 2014;12:7–19.
Sarvesvaran R. Sudden deaths associated with commercial air travel. Med Sci Law. 1986;26(1):35–8.
Schobersberger W. Traveller’s thrombosis: international consensus statement. Vasa. 2008;37:311–7.
Watson HG, Baglin TP. Guidelines on travel-related venous thrombosis. Br J Haematol. 2011;152(1):31–4.
Altitude Illness
Bartsch P, Swenson ER. Clinical practice: acute high-altitude illnesses. N Engl J Med. 2013;368(24):2294–302.
Hacket PH, Gallagher SA. High altitude disease: unique pediatric considerations. In Wiley JF (Ed.), UpToDate. 2019; retrieved 30 May 2019.
Hackett PH, Shlim DR. Chapter 2: The pretravel consultation—altitude illness. In: Centers for Disease Control and Prevention Yellow Book 2018: Health Information for International Travel. New York: Oxford University Press; 2017. https://wwwnc.cdc.gov/travel/yellowbook/2018/the-pre-travel-consultation/altitude-illness. Accessed 24 Dec 2018.
Kelly TE, Hackett PH. Acetazolamide and sulfonamide allergy: a not so simple story. High Alt Med Biol. 2010;11(4):319–23.
Lawrence JS, Reid ST. Risk determinants of Acute Mountain Sickness and Summit Success on a 6-day ascent of Mount Kilimanjaro (5895 m). Wilderness Environ Med. 2015;27(1):78–84.
Luks AM. Physiology in Medicine: a physiologic approach to prevention and treatment of acute high-altitude illnesses. J Appl Physiol. 2015;118:509–19.
Netzer N, Strohl K, et al. Hypoxia-related altitude illnesses. J Travel Med. 2013;20(4):247–55.
Parise I. Travelling safely to places at high altitude—understanding and preventing altitude illness. Aust Fam Physician. 2017;46(6):380–4.
Pollard AJ, Murdoch DR, Bärtsch P. Children in the mountains. BMJ. 1998;316:874–5.
Pollard AJ, Niermeyer S, Barry P, et al. Children at High Altitude: an international consensus statement by an ad hoc committee of the International Society for Mountain Medicine, March 12, 2001. High Alt Med Biol. 2001;2(3):389–403.
Yaron M, Niermeyer S. Travel to high altitude with young children: an approach for clinicians. High Alt Med Biol. 2008;9(4):265–9.
Zafren K. Prevention of high altitude illness. Travel Med Infect Dis. 2014;12(1):29–39.
Altitude Illness: Resources for Patients
CDC Traveler’s Health—Travel to High Altitudes (US). https://wwwnc.cdc.gov/travel/page/travel-to-high-altitudes.
Fit For Travel—Altitude and Travel (UK). https://www.fitfortravel.nhs.uk/advice/general-travel-health-advice/altitude-and-travel.
International Society for Mountain Medicine (ISMM) Public Resources. http://ismm.org/category/article/public/.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Torresi, J. et al. (2019). Non-infectious Problems. In: Manual of Travel Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-13-7252-0_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-7252-0_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7251-3
Online ISBN: 978-981-13-7252-0
eBook Packages: MedicineMedicine (R0)